DOT1L Shapes ncPRC1-Target Gene Repression to Maintain Germinal Center B Cell Identity of Diffuse Large B cell Lymphoma

C Camiel Göbel (Netherlands Cancer Institute, Amsterdam, Netherlands) R Rachele Niccolai (Netherlands Cancer Institute, Amsterdam, Netherlands) S Sebastian Gregoricchio M Marnix Hugo Philip de Groot (Netherlands Cancer Institute, Amsterdam, Netherlands) S Stijn F.K. Kneefel (Netherlands Cancer Institute, Amsterdam, Netherlands) M Maaike Kreft (Netherlands Cancer Institute, Amsterdam, Netherlands) H Hendrik J. Kuiken (Netherlands Cancer Institute, Amsterdam, Netherlands) C Cor Lieftink (Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute) N Nils Eickhoff (Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute) L Liesbeth Hoekman O Onno Bleijerveld (NKI-AvL, Amsterdam, Netherlands) W Wilbert Zwart R Roderick L Beijersbergen (The Netherlands Cancer Institute, Amsterdam, Netherlands) F Fred van Leeuwen (Netherlands Cancer Institute, Amsterdam, Netherlands) H Heinz Jacobs (Netherlands Cancer Institute, Amsterdam, Netherlands)

Abstract

Germinal center (GC) B cell-like diffuse large B cell lymphoma (GCB-DLBCL) depends on the cooperative activity of the histone methyltransferases DOT1L and EZH2 to maintain its pro-proliferative GCB cell identity while repressing plasma cell (PC) differentiation. To explore the mechanisms underlying the co-dependency between DOT1L and EZH2 in GCB-DLBCL, we performed an EZH2 inhibition (EZH2i)-anchored genome-wide CRISPR interference screen and identified multiple candidate genes encoding components of non-canonical (nc) PRC1 complexes, including USP7, KDM2B, RING1, and PCGF1. We identified USP7 as potential direct target of DOT1L, whose downregulation was associated with increased EZH2i sensitivity in multiple GCB-DLBCL cell lines. Furthermore, we observed that DOT1L influences the composition of chromatin-bound ncPRC1 complexes and regulates, in part, the deposition of H2AK119 monoubiquitination (H2AK119ub1) at gene promoters co-occupied by H3K27me3, here defined as PRC1/2 targets. These PRC1/2 targets were specifically enriched in PC signature genes, whose derepression was associated with DOT1L inhibition (DOT1Li)-mediated loss of H2AK119ub1. This study reveals novel insights into the role of DOT1L and its functional co-dependence with EZH2 in maintaining GCB identity in DLBCL, supporting a model in which concurrent reduction of H2AK119ub1 and H3K27me3 promotes differentiation toward an anti-proliferative, plasma cell-like state.

Article Details

Journal Blood
Volume / Issue Vol. 1, Issue 1
Published May 29, 2026
ISSN 0006-4971
Publisher Elsevier BV

Journal Info

Blood

Elsevier BV

ISSN: 0006-4971 Health Sciences

Authors (15)

C

Camiel Göbel

Netherlands Cancer Institute, Amsterdam, Netherlands

R

Rachele Niccolai

Netherlands Cancer Institute, Amsterdam, Netherlands

S

Sebastian Gregoricchio

M

Marnix Hugo Philip de Groot

Netherlands Cancer Institute, Amsterdam, Netherlands

S

Stijn F.K. Kneefel

Netherlands Cancer Institute, Amsterdam, Netherlands

M

Maaike Kreft

Netherlands Cancer Institute, Amsterdam, Netherlands

H

Hendrik J. Kuiken

Netherlands Cancer Institute, Amsterdam, Netherlands

C

Cor Lieftink

Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute

N

Nils Eickhoff

Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute

L

Liesbeth Hoekman

O

Onno Bleijerveld

NKI-AvL, Amsterdam, Netherlands

W

Wilbert Zwart

R

Roderick L Beijersbergen

The Netherlands Cancer Institute, Amsterdam, Netherlands

F

Fred van Leeuwen

Netherlands Cancer Institute, Amsterdam, Netherlands

H

Heinz Jacobs

Netherlands Cancer Institute, Amsterdam, Netherlands